Skip to main content

Semaglutide-Linked Suicidal Ideation ID'd in Disproportionality Analysis

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 21, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Aug. 21, 2024 -- Semaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open.

Georgios Schoretsanitis, M.D., Ph.D., from Northwell Health in Glen Oaks, New York, and colleagues examined potential signals for suicidal and self-injurious adverse drug reactions (ADRs) associated with the glucagon-like peptide 1 receptor agonists semaglutide and liraglutide in a disproportionality analysis. Participants were patients experiencing an ADR, which was suspected as attributable to semaglutide or liraglutide.

Overall, 107 and 162 cases of suicidal and/or self-injurious ADRs were reported between November 2000 and August 2023 for semaglutide and liraglutide, respectively. The researchers detected significant disproportionality for semaglutide-associated suicidal ideation (reporting odds ratio, 1.45), which remained significant for those coreporting antidepressant and benzodiazepine use (reporting odds ratios, 4.45 and 4.07, respectively) and compared with dapagliflozin, metformin, and orlistat (reporting odds ratios, 5.56, 3.86, and 4.24, respectively).

"We reported a disproportionality signal of suicidal ideation with semaglutide, but not for liraglutide, particularly among patients with coreported antidepressant use, a proxy for affective disorders (a notable exclusion criteria of premarketing clinical trials)," the authors write.

One author disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Longer Exposure to Antidepressants Increases Risk for Sudden Cardiac Death

WEDNESDAY, April 16, 2025 -- Exposure time to antidepressants in adults is associated with a higher risk for sudden cardiac death (SCD), according to a study presented at the...

Link Between Screen Time, Depression in Teens Mediated by Poor Sleep

MONDAY, April 7, 2025 -- The association between screen time and depression seen among adolescents is potentially mediated by poor sleep, according to a study published online...

Postpartum Hormonal Contraceptives Tied to Higher Depression Risk

THURSDAY, April 3, 2025 -- Use of hormonal contraceptives postpartum is associated with an increased risk for developing postpartum depression, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.